Fluconazole is indicated in the following fungal infections.
Fluconazole is indicated in adults for the treatment of: Coccidioidomycosis; Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria; Vaginal candidiasis, acute or recurrent, when local therapy is not appropriate; Candidal balanitis when local therapy is not appropriate; Dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated; Tinea unguinium (onychomycosis) when other agents are not considered appropriate.
Fluconazole is indicated in adults for the prophylaxis of: Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse; To reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year); Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation).